Status:
COMPLETED
A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Precancerous Gastric Lesions
Eligibility:
All Genders
35-65 years
Phase:
PHASE3
Brief Summary
The Division of Cancer Epidemiology and Genetics is conducting a collaborative randomized multi-intervention trial with the Beijing Institute for Cancer Research to evaluate the etiologic role of Heli...
Detailed Description
The Division of Cancer Epidemiology and Genetics is conducting an 8-year collaborative randomized multi-intervention trial with the Beijing Institute for Cancer Research to evaluate the etiologic role...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Ages 35-670 in the 14 Linqu villages who received endoscopy examinations in the fall of 1994.
- Both men and women will be included.
- Patients must sign an informed consent form indicating a willingness to participate in the 42-month trial.
- Must be free of debilitating chronic disease.
- Must not report allergies to penicillin or similar medications.
- Must not have had previous treatment for H. pylori.
- Must not have a history of bleeding disorder.
- Must not be taking vitamin/mineral supplements on a regular basis.
- EXCLUSION CRITERIA:
- Persons with cancer (except resected non-melanotic skin cancer), heart failure, emphysema, and other life-threatening illness will be excluded.
Exclusion
Key Trial Info
Start Date :
July 1 1995
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 1996
Estimated Enrollment :
3411 Patients enrolled
Trial Details
Trial ID
NCT00339768
Start Date
July 1 1995
End Date
June 10 1996
Last Update
December 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Institute for Cancer Research
Beijing, China